Growth Metrics

Dexcom (DXCM) EBT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -2.47%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.70%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 37.81%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 4.82%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 32.11%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 61.06%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.57%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 14.40%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 1.66%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 61.06%
Dec 31, 2025 36.76%
Sep 30, 2025 34.07%
Jun 30, 2025 47.39%
Mar 31, 2025 62.29%
Dec 31, 2024 220.80%
Sep 30, 2024 16.57%
Jun 30, 2024 24.59%
Mar 31, 2024 47.49%
Dec 31, 2023 16.88%
Sep 30, 2023 47.38%
Jun 30, 2023 51.07%
Mar 31, 2023 42.27%
Dec 31, 2022 12.20%
Sep 30, 2022 47.24%
Jun 30, 2022 116.14%
Mar 31, 2022 49.73%
Dec 31, 2021 26.75%
Sep 30, 2021 35.72%
Jun 30, 2021 48.59%
Mar 31, 2021 54.96%
Dec 31, 2020 161.74%
Sep 30, 2020 217.61%
Jun 30, 2020 73.34%
Mar 31, 2020 36.72%
Dec 31, 2019 149.18%
Sep 30, 2019 64.63%
Jun 30, 2019 22.66%
Mar 31, 2019 -11.48%
Dec 31, 2018 -382.83%
Sep 30, 2018 45.09%
Jun 30, 2018 115.44%
Mar 31, 2018 -22.99%
Dec 31, 2017 83.14%
Sep 30, 2017 21.66%
Jun 30, 2017 -33.89%
Mar 31, 2017 -47.73%
Dec 31, 2016 -39.12%
Sep 30, 2016 -45.81%
Jun 30, 2016 -25.78%
Mar 31, 2016 -20.04%
Dec 31, 2015 29.83%
Sep 30, 2015 -34.93%
Jun 30, 2015 36.86%
Mar 31, 2015 5.73%
Dec 31, 2014 28.36%
Sep 30, 2014 26.84%
Jun 30, 2014 6.61%
Mar 31, 2014 -1.80%
Dec 31, 2013 35.81%
Sep 30, 2013 22.89%
Jun 30, 2013 4.07%